Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04526067 · ClinicalTrials.gov registry record · NA

In-person vs. Remote Wellness Support

A NA study of Schizophrenia and Bipolar Disorder, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT04526067 is a NA study of Schizophrenia and Bipolar Disorder that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 56 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04526067, a NA study of Schizophrenia and Bipolar Disorder, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The study team will use components of the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework to compare Cognitive Adaptation Training (CAT) to Remotely delivered Cognitive Adaptation Training (R-CAT) 1-9 within a managed care organization (MCO), targeting members with serious mental illness (SMI) needing assistance with the regular taking of medication.

Interventions

  • BEHAVIORAL CAT
  • BEHAVIORAL R-CAT

Study Locations (1)

Texas

  • University of Texas Health Science Center - Department of Psychiatry - San Antonio

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2020-11-24
Est. Completion 2022-11-11
Phase NA

What the Registry Record Tells You About NCT04526067

The ClinicalTrials.gov registry entry for NCT04526067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (74% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which CAT is the first listed.

NCT04526067 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04526067 about?

NCT04526067 is a clinical study titled "In-person vs. Remote Wellness Support". The study team will use components of the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework to compare Cognitive Adaptation Training (CAT) to Remotely delivered Cognitive Adaptation Training (R-CAT) 1-9 within a managed care organization (MCO), targeting members with ser...

What is the current status of trial NCT04526067?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2020-11-24. Estimated completion is 2022-11-11.

What conditions does trial NCT04526067 study?

This clinical trial studies the following conditions: Schizophrenia, Bipolar Disorder, Depressive Disorder, Major, Schizo Affective Disorder.

What interventions are being tested in trial NCT04526067?

The interventions under investigation include: CAT (BEHAVIORAL), R-CAT (BEHAVIORAL).

Who is sponsoring clinical trial NCT04526067?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04526067 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.